The cost of domestic violence to the Australian economy: Part 1 A Economics Commonwealth of Australia 90, 2004 | 71* | 2004 |
Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ... Pharmacoeconomics 33 (9), 905-924, 2015 | 65 | 2015 |
Cost‐effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparator B Parkinson, S Goodall, P Thavaneswaran ANZ Journal of Surgery 83 (9), 669-675, 2013 | 49 | 2013 |
Financial cost of lymphedema borne by women with breast cancer J Boyages, Y Xu, S Kalfa, L Koelmeyer, B Parkinson, H Mackie, H Viveros, ... Psycho‐oncology 26 (6), 849-855, 2017 | 46 | 2017 |
Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus L Vallejo-Torres, L Steuten, B Parkinson, AJ Girling, MJ Buxton Medical Decision Making 31 (4), 596-610, 2011 | 38 | 2011 |
Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents JM Langton, P Srasuebkul, R Reeve, B Parkinson, Y Gu, NA Buckley, ... Implementation Science 10 (1), 25, 2015 | 28 | 2015 |
Cost of Cancer in NSW A Economics Sydney: Cancer Council of NSW, 2007 | 24 | 2007 |
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique B Parkinson, SA Pearson, R Viney The European Journal of Health Economics 15 (1), 93-112, 2014 | 21 | 2014 |
The cost-effectiveness of mandatory folic acid fortification in Australia V Rabovskaja, B Parkinson, S Goodall The Journal of nutrition 143 (1), 59-66, 2013 | 21 | 2013 |
Living with Parkinson’s disease: challenges and positive steps for the future A Economics Report for Parkinson’s Australia (Access Economics), 2007 | 14 | 2007 |
Investigating consumer medicine information (I-CMI) project P Aslani, K Hamrosi, E Feletto, DK Raynor, P Knapp, B Parkinson Sydney: The Pharmacy Guild of Australia, Australian Government Department of …, 2010 | 12 | 2010 |
Considering consumer choice in the economic evaluation of mandatory health programmes: A review B Parkinson, S Goodall Health policy 101 (3), 236-244, 2011 | 11 | 2011 |
Real-world evidence: a comparison of The Australian Herceptin Program and clinical trials of trastuzumab for HER2-positive metastatic breast cancer B Parkinson, R Viney, M Haas, S Goodall, P Srasuebkul, SA Pearson Pharmacoeconomics 34 (10), 1039-1050, 2016 | 10 | 2016 |
Cost‐effectiveness of the BRECONDA decision aid for women with breast cancer: Results from a randomized controlled trial B Parkinson, KA Sherman, P Brown, LKE Shaw, J Boyages, LD Cameron, ... Psycho‐oncology 27 (6), 1589-1596, 2018 | 9 | 2018 |
Long‐term health care costs for patients with prostate cancer: a population‐wide longitudinal study in New South Wales, Australia P Cronin, B Kirkbride, A Bang, B Parkinson, D Smith, P Haywood Asia‐Pacific Journal of Clinical Oncology 13 (3), 160-171, 2017 | 8 | 2017 |
Investigating consumer medicine information (CMI) report. CMI effectiveness tender P Aslani, K Hamrosi, E Feletto, P Knapp, B Parkinson, J Hughes, L Nissen, ... The Pharmacy Guild of Australia and Department of Health and Ageing, 2010 | 7 | 2010 |
Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol A Morrow, E Hogden, YJ Kang, J Steinberg, K Canfell, MJ Solomon, ... Trials 20 (1), 1-12, 2019 | 6 | 2019 |
The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience TV Ariyaratne, Z Ademi, M Huq, F Rosenfeldt, SJ Duffy, B Parkinson, ... Applied health economics and health policy 16 (5), 661-674, 2018 | 5 | 2018 |
Comment on:" Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review"/Authors' Reply to Palozzo and Messori:" Disinvestment and Value … AC Palozzo, A Messori, B Parkinson, AG Elshaug Pharmacoeconomics 34 (4), 419, 2016 | 5 | 2016 |
Discounting in economic evaluations in health care: A brief review B Parkinson, RDA Lourenço | 5 | 2015 |